Compumedics Limited (ASX:CMP) announces a share repurchase program. Under the program, the company will repurchase up to 4,000,000 shares, representing 2.26% of its issued share capital. The purpose of the program is y to add value to the remaining shares on issue and reflect the true value of shares.

The program is valid until August 10, 2023. As of August 11, 2022, the company had 177,162,948 ordinary shares in issue.